Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Amicus, GSK Initiate Second Phase 3 Trial Of Amigal For Fabry Disease - RTT News |
 |
 |
|
RTT News The companies noted that the primary outcome of efficacy will be renal function as measured by glomerular filtration rate for the migalastat HCl and ERT groups at 18 months. Secondary outcomes of efficacy include renal function as measured by 24-hour ... Amicus Therapeutics and GlaxoSmithKline Commence Second Phase 3 Study of |
